Business Description
BeiGene Ltd
NAICS : 325412
ISIN : CNE100005XT6
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.41 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.26 | |||||
Debt-to-EBITDA | -0.83 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.38 | |||||
Beneish M-Score | -1.71 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 85.3 | |||||
3-Year EBITDA Growth Rate | 18 | |||||
3-Year EPS without NRI Growth Rate | 24.3 | |||||
3-Year FCF Growth Rate | 2.4 | |||||
3-Year Book Growth Rate | -7.1 | |||||
Future 3-5Y Total Revenue Growth Rate | 24.93 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.9 | |||||
9-Day RSI | 51.41 | |||||
14-Day RSI | 48.76 | |||||
6-1 Month Momentum % | 0.02 | |||||
12-1 Month Momentum % | -17.6 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.32 | |||||
Quick Ratio | 2.09 | |||||
Cash Ratio | 1.75 | |||||
Days Inventory | 313.91 | |||||
Days Sales Outstanding | 43.03 | |||||
Days Payable | 280.55 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.5 | |||||
Shareholder Yield % | -0.21 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 84.55 | |||||
Operating Margin % | -49.12 | |||||
Net Margin % | -35.86 | |||||
FCF Margin % | -70.53 | |||||
ROE % | -22.45 | |||||
ROA % | -15 | |||||
ROIC % | -60.1 | |||||
ROC (Joel Greenblatt) % | -103.23 | |||||
ROCE % | -27.23 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.56 | |||||
PB Ratio | 3.91 | |||||
Price-to-Tangible-Book | 4.04 | |||||
EV-to-EBIT | -10.8 | |||||
EV-to-Forward-EBIT | -11.09 | |||||
EV-to-EBITDA | -11.65 | |||||
EV-to-Forward-EBITDA | -15.22 | |||||
EV-to-Revenue | 5.26 | |||||
EV-to-Forward-Revenue | 4.25 | |||||
EV-to-FCF | -7.02 | |||||
Price-to-Net-Current-Asset-Value | 7.15 | |||||
Price-to-Net-Cash | 15.27 | |||||
Earnings Yield (Greenblatt) % | -9.26 | |||||
FCF Yield % | -11.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
BeiGene Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 17,580.369 | ||
EPS (TTM) (Â¥) | -4.63 | ||
Beta | 0 | ||
Volatility % | 53.7 | ||
14-Day RSI | 48.76 | ||
14-Day ATR (Â¥) | 4.452994 | ||
20-Day SMA (Â¥) | 126.245 | ||
12-1 Month Momentum % | -17.6 | ||
52-Week Range (Â¥) | 98.5 - 165.28 | ||
Shares Outstanding (Mil) | 1,358.37 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BeiGene Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BeiGene Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
BeiGene Ltd Frequently Asked Questions
What is BeiGene Ltd(SHSE:688235)'s stock price today?
When is next earnings date of BeiGene Ltd(SHSE:688235)?
Does BeiGene Ltd(SHSE:688235) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |